The deal is contingent on market approval from regulatory agencies and other standard conditions, including product quality. The parties do not foresee any significant regulatory obstacles, as the product has a low-risk classification, and most of the documentation is already in place. Intellego will have to continue to invest in the market together with Likang during the time period up until market launch and afterwards. The volumes will be achieved over a five-year period, with volumes increasing progressively over time. The sales launch is projected to occur in late 2025.
Zhongyou Medical (Likang) is a wholly owned subsidiary of Jiangsu Yuyue Medical Equipment and Supply Co., Ltd, which is listed on the Shenzhen Stock market, a leading distributor of a variety of disinfectant products into more than 3000 hospitals in China nationally.

Yuwell medical, with full name of Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. has established 12 R&D centers and 9 production bases in Shanghai, Shenzhen, Nanjing, Suzhou, Danyang, Tibet, the Netherlands, Germany, Italy, and other places, forming a complete global R&D, production, marketing, and service network that serves more than 300,000 medical institutions worldwide and covers 131 countries and regions, benefitting 300 million households around the world. https://www.yuwell.com/